PMID- 22066590 OWN - NLM STAT- MEDLINE DCOM- 20120424 LR - 20211021 IS - 1526-4602 (Electronic) IS - 1525-7797 (Print) IS - 1525-7797 (Linking) VI - 13 IP - 1 DP - 2012 Jan 9 TI - Imaging of homeostatic, neoplastic, and injured tissues by HA-based probes. PG - 12-22 LID - 10.1021/bm201143c [doi] AB - An increase in hyaluronan (HA) synthesis, cellular uptake, and metabolism occurs during the remodeling of tissue microenvironments following injury and during disease processes such as cancer. We hypothesized that multimodality HA-based probes selectively target and detectably accumulate at sites of high HA metabolism, thus providing a flexible imaging strategy for monitoring disease and repair processes. Kinetic analyses confirmed favorable available serum levels of the probe following intravenous (i.v.) or subcutaneous (s.c.) injection. Nuclear (technetium-HA, (99m)Tc-HA, and iodine-HA, (125)I-HA), optical (fluorescent Texas Red-HA, TR-HA), and magnetic resonance (gadolinium-HA, Gd-HA) probes imaged liver ((99m)Tc-HA), breast cancer cells/xenografts (TR-HA, Gd-HA), and vascular injury ((125)I-HA, TR-HA). Targeting of HA probes to these sites appeared to result from selective HA receptor-dependent localization. Our results suggest that HA-based probes, which do not require polysaccharide backbone modification to achieve favorable half-life and distribution, can detect elevated HA metabolism in homeostatic, injured, and diseased tissues. FAU - Veiseh, Mandana AU - Veiseh M AD - Division of Life Sciences, Lawrence Berkeley National Laboratories, Berkeley, California, USA. FAU - Breadner, Daniel AU - Breadner D FAU - Ma, Jenny AU - Ma J FAU - Akentieva, Natalia AU - Akentieva N FAU - Savani, Rashmin C AU - Savani RC FAU - Harrison, Rene AU - Harrison R FAU - Mikilus, David AU - Mikilus D FAU - Collis, Lisa AU - Collis L FAU - Gustafson, Stefan AU - Gustafson S FAU - Lee, Ting-Yim AU - Lee TY FAU - Koropatnick, James AU - Koropatnick J FAU - Luyt, Leonard G AU - Luyt LG FAU - Bissell, Mina J AU - Bissell MJ FAU - Turley, Eva A AU - Turley EA LA - eng GR - R01 HL062472/HL/NHLBI NIH HHS/United States GR - MOP82720/CAPMC/CIHR/Canada GR - R37 CA064786/CA/NCI NIH HHS/United States GR - U54 CA143836/CA/NCI NIH HHS/United States GR - U54CA143836/CA/NCI NIH HHS/United States GR - R37CA064786/CA/NCI NIH HHS/United States GR - F32 CA132491/CA/NCI NIH HHS/United States GR - U54 CA112970/CA/NCI NIH HHS/United States GR - U01CA143233/CA/NCI NIH HHS/United States GR - R01 CA057621/CA/NCI NIH HHS/United States GR - R01CA057621/CA/NCI NIH HHS/United States GR - U01 CA143233/CA/NCI NIH HHS/United States GR - FCA132491A/PHS HHS/United States GR - U54CA126552/CA/NCI NIH HHS/United States GR - U54CA112970/CA/NCI NIH HHS/United States GR - R01 HL075930/HL/NHLBI NIH HHS/United States GR - U54 CA126552/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20111212 PL - United States TA - Biomacromolecules JT - Biomacromolecules JID - 100892849 RN - 0 (Molecular Probes) RN - 9004-61-9 (Hyaluronic Acid) SB - IM MH - Animals MH - Cell Line, Tumor MH - Female MH - Humans MH - Hyaluronic Acid/chemistry/*metabolism MH - *Liver Neoplasms, Experimental/metabolism/pathology MH - Magnetic Resonance Imaging/*methods MH - *Mammary Neoplasms, Experimental/metabolism/pathology MH - Mice MH - *Molecular Probes/chemistry/pharmacology MH - Neoplasm Transplantation MH - Rats MH - Rats, Nude MH - Tomography, Optical/*methods MH - Transplantation, Heterologous MH - Tumor Microenvironment MH - *Vascular Diseases/metabolism/pathology PMC - PMC3658319 MID - NIHMS466638 EDAT- 2011/11/10 06:00 MHDA- 2012/04/25 06:00 PMCR- 2013/05/20 CRDT- 2011/11/10 06:00 PHST- 2011/11/10 06:00 [entrez] PHST- 2011/11/10 06:00 [pubmed] PHST- 2012/04/25 06:00 [medline] PHST- 2013/05/20 00:00 [pmc-release] AID - 10.1021/bm201143c [doi] PST - ppublish SO - Biomacromolecules. 2012 Jan 9;13(1):12-22. doi: 10.1021/bm201143c. Epub 2011 Dec 12.